StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

JAZZ — Jazz Pharmaceuticals plc

UNDERVALUED (MOS +30.1%) · Quality 68/100

Price
240.74
Intrinsic value
344.53
Margin of safety
+30.1%
Implied growth (reverse DCF)
-1.9%
model assumes +2.5%
Value Score
41.2
Quality
68
Psychology
8
Discovery
27.3
price/volume attention only
Moat score
28
erosion: none

Value Score: top 47% of Russell 3000 · Quality: top 40%

Open the interactive Deep Dive for JAZZ →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/JAZZ - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is JAZZ undervalued?

As of 2026-09-19, JAZZ trades at 240.74 against a computed intrinsic value of 344.53 (+30.1% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Jazz Pharmaceuticals plc's Value Score?

Jazz Pharmaceuticals plc's Value Score is 41.2 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.